Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
It can lead to fluid retention, which increases the workload on the heart
Here is what we know so far: Type 2 Diabetes Management GLP-1 medications are approved by the FDA as a second line of defence against type 2 diabetes after the diabetic drug, Metformin
Its active ingredient, semaglutide, is part of a drug class called GLP-1 receptor agonists
A New Paradigm for Treating to Target with Second-Generation Obesity Medications
For women with known PCOS or other reproductive endocrine conditions, baseline and follow-up assessments of metabolic and reproductive parameters can help distinguish medication effects from underlying disease progression
Nausea and Vomiting Nausea is the most commonly reported side effect of semaglutide, with around 44% of people using Wegovy, experiencing nausea during clinical trials resulting in 6.8% of patients permanently discontinuing treatment as the result of adverse reactions
US$ 20.77
US$ 25.91
US$ 27.97
US$ 28.74
